ANI Pharmaceuticals
ANIP
#4658
Rank
โ‚ฌ1.30 B
Marketcap
59,95ย โ‚ฌ
Share price
4.61%
Change (1 day)
-4.36%
Change (1 year)

Revenue for ANI Pharmaceuticals (ANIP)

Revenue in 2024 (TTM): โ‚ฌ0.57 Billion

According to ANI Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.54 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.44 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ANI Pharmaceuticals from 2000 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.59 B34.07%
2023 โ‚ฌ0.44 B49.3%
2022 โ‚ฌ0.29 B54.55%
2021 โ‚ฌ0.19 B12.6%
2020 โ‚ฌ0.16 B-8.07%
2019 โ‚ฌ0.18 B4.64%
2018 โ‚ฌ0.17 B19.55%
2017 โ‚ฌ0.14 B20.53%
2016 โ‚ฌ0.12 B75.18%
2015 โ‚ฌ69.8 M51.68%
2014 โ‚ฌ46.02 M157.67%
2013 โ‚ฌ17.86 M926.86%
2012 โ‚ฌ1.73 M419.07%
2011 โ‚ฌ0.33 M-81.99%
2010 โ‚ฌ1.86 M111.84%
2009 โ‚ฌ0.87 M-67.38%
2008 โ‚ฌ2.69 M697.2%
2007 โ‚ฌ0.33 M-96.91%
2006 โ‚ฌ10.94 M4917.41%
2005 โ‚ฌ0.21 M279.84%
2004 โ‚ฌ0.05 M
2001 โ‚ฌ2.03 M3018.62%
2000 โ‚ฌ0.06 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ3.58 B 562.29%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
โ‚ฌ9.01 M-98.33%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ14.55 B 2,592.65%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ55.99 B 10,256.20%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ0.27 B-49.43%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ6.17 M-98.86%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ195.50 B 36,060.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ45.51 B 8,318.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
โ‚ฌ1.99 B 268.43%๐Ÿ‡ฌ๐Ÿ‡ง UK